Pieris Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.20-$22.32 |
Market Cap | $21.1M |
Shares Short | 23,561 |
Financials
See moreRevenue (12 Mos) | $20.8M |
Revenue Growth (YoY) | -97.3% |
Gross Profit (12 Mos) | -$27M |
Diluted EPS | -$12.11 |
News
See moreYahoo Finance • 2 years ago
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
Yahoo Finance • 2 years ago
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Analysts Just Cut Their EPS Forecasts Substantially
Yahoo Finance • 2 years ago
OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension
Yahoo Finance • 2 years ago
Pieris Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
About
CEO | Mr. Stephen S. Yoder J.D. |
Address | 225 Franklin Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 46 |
